The 2025-2030 World Outlook for Glaucoma Pharmaceuticals - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Glaucoma Pharmaceuticals

Subjects

Out of stock

Price data checked 4 days ago

View at Amazon

One email. No newsletter. No nudges.

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Out of stock 4 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This study covers the world outlook for glaucoma pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of glaucoma pharmaceuticals as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Acadia Pharmaceuticals, Alcon Laboratories, Allergan, Falcon Pharmaceuticals, and Inotek Pharmaceuticals Corporation. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CYF2MRY9
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 04 April 2024

The 2025-2030 World Outlook for Glaucoma Pharmaceuticals

Sold out. We send one email the moment it's back. Last time, that took just a day or two.

Price History & Forecast

Price Distribution

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in the United States

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in Japan

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in India

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics for US Zip Codes

Diagnosis and Analysis of Glaucoma using AI and ML for Medical Imaging

Glaucoma Update III: Glaucoma Society of the International Congress of Ophthalmology, Amsterdam, September 1986

The Mystery of Glaucoma by IntechOpen - Medical Book

The 2021-2026 World Outlook for Intraocular Pressure Monitoring Devices

Automated Diagnosis of Glaucoma Using AI Techniques: Neural Networks, Decision Trees, Naïve Bayes, and Support Vector Machine

The Glaucoma Handbook: Evidence-based Clinical Care

Symposium on Medical Therapy in Glaucoma, Amsterdam, May 15, 1976: 12 (Documenta Ophthalmologica Proceedings Series, 12)

Glaucoma: An Issue of Ophthalmology Clinics

Glaucoma

Pearls of Glaucoma Management

Surgical Management of Childhood Glaucoma: Clinical Considerations and Techniques

The 2025-2030 World Outlook for 3D Glasses

The 2025-2030 World Outlook for Optical Goods and Eye Care Products

Cataract Surgery in the Glaucoma Patient

The 2025-2030 World Outlook for Eyeglasses

The 2025-2030 World Outlook for Vision Care

The 2023-2028 World Outlook for Vision Care

The 2021-2026 World Outlook for Uveitis Treatments

The 2025-2030 World Outlook for Myopia and Presbyopia Treatments